Treatment Options for Eczema
The management of eczema follows a stepwise approach, with topical corticosteroids being the first-line treatment for flare-ups, followed by topical calcineurin inhibitors, phototherapy, and systemic therapies for more severe cases that don't respond to initial treatments. 1
First-Line Treatment
Moisturizers and Skin Care
- Apply emollients liberally and frequently, especially after bathing
- Use soap-free cleansers for bathing
- Continue moisturizer use even when skin appears clear
Topical Corticosteroids
Potency selection:
Application frequency:
- Once-daily application of potent corticosteroids is as effective as twice-daily application 2
- Apply to affected areas only
Duration:
- Use for short periods during flares
- Stop when signs and symptoms (itching, rash, redness) resolve 3
Topical Calcineurin Inhibitors (TCIs)
- Options include pimecrolimus (Elidel) and tacrolimus
- Particularly useful for:
- Pimecrolimus is indicated for patients 2 years and older 3
- Do not use continuously for long periods 3
Second-Line Treatment
Proactive Maintenance Therapy
- Weekend (twice weekly) application of topical corticosteroids or TCIs to previously affected areas reduces relapse risk by more than 50% 2
- Helps prevent recurrent flares
Phototherapy
- Consider when topical therapies fail to control symptoms
- Narrow-band UVB is most commonly recommended 1
- May cause long-term adverse effects such as premature skin aging and cutaneous malignancies 4
Third-Line Treatment
Systemic Therapies
Reserved for severe, recalcitrant cases that don't respond to topical treatments
Options include:
Systemic corticosteroids:
Adjunctive Treatments
Infection Prevention and Management
- Bleach baths (0.005% sodium hypochlorite twice weekly) help prevent infections
- Systemic antibiotics only when clear evidence of infection 1
Antihistamines
Allergen Management
- Consider dietary manipulation only when history strongly suggests food allergy
- Evidence for house dust mite eradication is not strong 4
Important Considerations and Cautions
Safety of Topical Corticosteroids
- Risk of skin thinning is low when used appropriately
- In long-term studies, only 1 case of skin atrophy was reported among 1213 patients using mild/moderate potency TCS for up to 5 years 7
- Adrenal suppression is rare with appropriate use 7
- Avoid prolonged use of high-potency corticosteroids on sensitive areas 1
Common Mistakes to Avoid
- Undertreatment due to "steroid phobia"
- Prolonged use of high-potency topical corticosteroids on sensitive areas
- Relying on antihistamines for daytime itch control
- Using systemic corticosteroids as regular treatment 1
When to Refer to a Specialist
- Failure to respond to first-line management
- Uncertain diagnosis
- Severe or widespread disease
- Need for systemic therapy 4
Special Populations
- Children under 2 years: Avoid pimecrolimus 3
- Sensitive areas (face, neck, skin folds): Prefer topical calcineurin inhibitors over corticosteroids 1
The evidence supports a structured approach to eczema management, with appropriate selection of treatments based on disease severity, affected areas, and response to initial therapy.